Novel motif:141
From FANTOM5_SSTAR
name: | motif141_TTAAACGGC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0060676 | ureteric bud formation | 5.582865e-10 |
GO:0046013 | regulation of T cell homeostatic proliferation | 1.765947e-9 |
GO:0002689 | negative regulation of leukocyte chemotaxis | 7.129581e-9 |
GO:0060458 | right lung development | 7.984092e-8 |
GO:0060461 | right lung morphogenesis | 1.189909e-7 |
GO:0090131 | mesenchyme migration | 1.189909e-7 |
GO:0060446 | branching involved in open tracheal system development | 1.189909e-7 |
GO:0014822 | detection of wounding | 1.189909e-7 |
GO:0048371 | lateral mesodermal cell differentiation | 1.189909e-7 |
GO:0048613 | embryonic ectodermal digestive tract morphogenesis | 1.189909e-7 |
GO:0043438 | acetoacetic acid metabolic process | 2.683360e-7 |
GO:0030970 | retrograde protein transport, ER to cytosol | 2.741506e-7 |
GO:0045198 | establishment of epithelial cell apical/basal polarity | 4.748253e-7 |
GO:0061015 | snRNA import into nucleus | 5.022677e-7 |
GO:0048370 | lateral mesoderm formation | 8.058175e-7 |
GO:0019605 | butyrate metabolic process | 9.502970e-7 |
GO:0043305 | negative regulation of mast cell degranulation | 9.558919e-7 |
GO:0002686 | negative regulation of leukocyte migration | 1.390276e-6 |
GO:0006924 | activation-induced cell death of T cells | 1.650557e-6 |
GO:0032102 | negative regulation of response to external stimulus | 2.594312e-6 |
GO:0000082 | G1/S transition of mitotic cell cycle | 2.805686e-6 |
GO:0032594 | protein transport within lipid bilayer | 3.768390e-6 |
GO:0070192 | chromosome organization involved in meiosis | 5.340881e-6 |
GO:0046459 | short-chain fatty acid metabolic process | 5.400100e-6 |
GO:0048368 | lateral mesoderm development | 5.833555e-6 |
GO:0042413 | carnitine catabolic process | 6.752654e-6 |
GO:0042758 | long-chain fatty acid catabolic process | 6.752654e-6 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 6.869692e-6 |
GO:0031327 | negative regulation of cellular biosynthetic process | 6.895623e-6 |
GO:0001656 | metanephros development | 7.596983e-6 |
GO:0050687 | negative regulation of defense response to virus | 9.486955e-6 |
GO:0071625 | vocalization behavior | 1.026980e-5 |
GO:0060426 | lung vasculature development | 1.183561e-5 |
GO:0009890 | negative regulation of biosynthetic process | 1.479656e-5 |
GO:0010976 | positive regulation of neuron projection development | 1.550291e-5 |
GO:0050798 | activated T cell proliferation | 1.761742e-5 |
GO:0019254 | carnitine metabolic process, CoA-linked | 2.031248e-5 |
GO:0001808 | negative regulation of type IV hypersensitivity | 2.038710e-5 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 2.067848e-5 |
GO:0035089 | establishment of apical/basal cell polarity | 2.080860e-5 |
GO:0007129 | synapsis | 2.206709e-5 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 2.459112e-5 |
GO:0001807 | regulation of type IV hypersensitivity | 2.563321e-5 |
GO:0060004 | reflex | 2.611316e-5 |
GO:0031324 | negative regulation of cellular metabolic process | 2.694177e-5 |
GO:0072189 | ureter development | 2.721860e-5 |
GO:0043301 | negative regulation of leukocyte degranulation | 2.745802e-5 |
GO:0035372 | protein localization to microtubule | 3.031492e-5 |
GO:0009954 | proximal/distal pattern formation | 3.861958e-5 |
GO:0010591 | regulation of lamellipodium assembly | 3.879172e-5 |
GO:0090162 | establishment of epithelial cell polarity | 4.149116e-5 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 4.152135e-5 |
GO:0060629 | regulation of homologous chromosome segregation | 4.315181e-5 |
GO:0051598 | meiotic recombination checkpoint | 4.315181e-5 |
GO:0045234 | protein palmitoleylation | 4.315181e-5 |
GO:0006948 | induction by virus of host cell-cell fusion | 4.315181e-5 |
GO:0071109 | superior temporal gyrus development | 4.376941e-5 |
GO:0015824 | proline transport | 4.547463e-5 |
GO:0030859 | polarized epithelial cell differentiation | 4.717375e-5 |
GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus | 4.731461e-5 |
GO:0009892 | negative regulation of metabolic process | 4.810296e-5 |
GO:0033007 | negative regulation of mast cell activation involved in immune response | 5.767142e-5 |
GO:0043519 | regulation of myosin II filament organization | 6.143226e-5 |
GO:0051030 | snRNA transport | 6.772209e-5 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 7.099672e-5 |
GO:0070231 | T cell apoptosis | 7.230366e-5 |
GO:0042438 | melanin biosynthetic process | 7.533715e-5 |
GO:0072088 | nephron epithelium morphogenesis | 7.604067e-5 |
GO:0043697 | cell dedifferentiation | 7.957133e-5 |
GO:2000773 | negative regulation of cellular senescence | 7.957133e-5 |
GO:0046827 | positive regulation of protein export from nucleus | 8.023944e-5 |
GO:0042130 | negative regulation of T cell proliferation | 8.148315e-5 |
GO:0071732 | cellular response to nitric oxide | 8.598002e-5 |
GO:0070317 | negative regulation of G0 to G1 transition | 8.607487e-5 |
GO:0045926 | negative regulation of growth | 9.204941e-5 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 9.239508e-5 |
GO:0003214 | cardiac left ventricle morphogenesis | 9.763949e-5 |
GO:0051253 | negative regulation of RNA metabolic process | 1.007581e-4 |
GO:0046824 | positive regulation of nucleocytoplasmic transport | 1.068431e-4 |
GO:0050672 | negative regulation of lymphocyte proliferation | 1.069175e-4 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 1.121204e-4 |
GO:0042104 | positive regulation of activated T cell proliferation | 1.168039e-4 |
GO:0030538 | embryonic genitalia morphogenesis | 1.196642e-4 |
GO:0072028 | nephron morphogenesis | 1.250743e-4 |
GO:0051177 | meiotic sister chromatid cohesion | 1.266940e-4 |
GO:0043113 | receptor clustering | 1.283177e-4 |
GO:0034371 | chylomicron remodeling | 1.458846e-4 |
GO:0071205 | protein localization to juxtaparanode region of axon | 1.484179e-4 |
GO:0001831 | trophectodermal cellular morphogenesis | 1.685834e-4 |
GO:0033211 | adiponectin-mediated signaling pathway | 1.719801e-4 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.764117e-4 |
GO:0048557 | embryonic digestive tract morphogenesis | 1.855685e-4 |
GO:0035148 | tube formation | 2.027972e-4 |
GO:0042102 | positive regulation of T cell proliferation | 2.127556e-4 |
GO:0033004 | negative regulation of mast cell activation | 2.193498e-4 |
GO:0019060 | intracellular transport of viral proteins in host cell | 2.261330e-4 |
GO:0043901 | negative regulation of multi-organism process | 2.299154e-4 |
GO:0072009 | nephron epithelium development | 2.338643e-4 |
GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 2.373301e-4 |
GO:0048680 | positive regulation of axon regeneration | 2.448115e-4 |
GO:0015881 | creatine transport | 2.566289e-4 |
GO:0000237 | leptotene | 2.566289e-4 |
GO:0050922 | negative regulation of chemotaxis | 2.734569e-4 |
GO:0002437 | inflammatory response to antigenic stimulus | 2.743961e-4 |
GO:2000272 | negative regulation of receptor activity | 2.769164e-4 |
GO:0045161 | neuronal ion channel clustering | 2.812442e-4 |
GO:0001562 | response to protozoan | 3.267450e-4 |
GO:0032438 | melanosome organization | 3.368908e-4 |
GO:0031290 | retinal ganglion cell axon guidance | 3.368908e-4 |
GO:0015820 | leucine transport | 3.563709e-4 |
GO:0048619 | embryonic hindgut morphogenesis | 3.606203e-4 |
GO:0006582 | melanin metabolic process | 3.632204e-4 |
GO:0060463 | lung lobe morphogenesis | 3.748631e-4 |
GO:0060662 | salivary gland cavitation | 3.764459e-4 |
GO:0046322 | negative regulation of fatty acid oxidation | 3.826490e-4 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 3.871633e-4 |
GO:0046621 | negative regulation of organ growth | 3.999106e-4 |
GO:0035553 | oxidative single-stranded RNA demethylation | 4.081976e-4 |
GO:0032513 | negative regulation of protein phosphatase type 2B activity | 4.081976e-4 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.243048e-4 |
GO:0022007 | convergent extension involved in neural plate elongation | 4.243048e-4 |
GO:0046006 | regulation of activated T cell proliferation | 4.334932e-4 |
GO:0090316 | positive regulation of intracellular protein transport | 4.402850e-4 |
GO:0043084 | penile erection | 4.433899e-4 |
GO:0045163 | clustering of voltage-gated potassium channels | 4.703041e-4 |
GO:0070227 | lymphocyte apoptosis | 4.834515e-4 |
GO:0046836 | glycolipid transport | 4.907410e-4 |
GO:0030214 | hyaluronan catabolic process | 5.100884e-4 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 5.110207e-4 |
GO:0048343 | paraxial mesodermal cell fate commitment | 5.176602e-4 |
GO:0001659 | temperature homeostasis | 5.210792e-4 |
GO:0030308 | negative regulation of cell growth | 5.329882e-4 |
GO:0072073 | kidney epithelium development | 5.370557e-4 |
GO:0060644 | mammary gland epithelial cell differentiation | 5.444068e-4 |
GO:0010560 | positive regulation of glycoprotein biosynthetic process | 5.472315e-4 |
GO:0002698 | negative regulation of immune effector process | 5.629805e-4 |
GO:0035411 | catenin import into nucleus | 5.722692e-4 |
GO:0010629 | negative regulation of gene expression | 5.784200e-4 |
GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development | 5.900027e-4 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 6.096832e-4 |
GO:0015826 | threonine transport | 6.247547e-4 |
GO:0034589 | hydroxyproline transport | 6.247547e-4 |
GO:0070193 | synaptonemal complex organization | 6.623714e-4 |
GO:0032388 | positive regulation of intracellular transport | 6.629414e-4 |
GO:0042245 | RNA repair | 6.918015e-4 |
GO:0042138 | meiotic DNA double-strand break formation | 6.918015e-4 |
GO:0033313 | meiotic cell cycle checkpoint | 6.918015e-4 |
GO:0001838 | embryonic epithelial tube formation | 7.099570e-4 |
GO:0008054 | cyclin catabolic process | 7.544699e-4 |
GO:0002042 | cell migration involved in sprouting angiogenesis | 7.772383e-4 |
GO:0030514 | negative regulation of BMP signaling pathway | 7.773506e-4 |
GO:0043570 | maintenance of DNA repeat elements | 7.894369e-4 |
GO:0044275 | cellular carbohydrate catabolic process | 8.293593e-4 |
GO:0033631 | cell-cell adhesion mediated by integrin | 8.631110e-4 |
GO:0010592 | positive regulation of lamellipodium assembly | 8.739515e-4 |
GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 8.765305e-4 |
GO:0045906 | negative regulation of vasoconstriction | 9.018771e-4 |
GO:0072175 | epithelial tube formation | 9.581411e-4 |
GO:0070664 | negative regulation of leukocyte proliferation | 9.804486e-4 |
GO:0033629 | negative regulation of cell adhesion mediated by integrin | 9.834169e-4 |
GO:0048714 | positive regulation of oligodendrocyte differentiation | 1.095187e-3 |
GO:0072273 | metanephric nephron morphogenesis | 1.099555e-3 |
GO:0060231 | mesenchymal to epithelial transition | 1.179207e-3 |
GO:0048753 | pigment granule organization | 1.199766e-3 |
GO:0060631 | regulation of meiosis I | 1.212180e-3 |
GO:0001574 | ganglioside biosynthetic process | 1.219108e-3 |
GO:0042475 | odontogenesis of dentine-containing tooth | 1.246698e-3 |
GO:0033002 | muscle cell proliferation | 1.254343e-3 |
GO:0045872 | positive regulation of rhodopsin gene expression | 1.259539e-3 |
GO:0016052 | carbohydrate catabolic process | 1.280579e-3 |
GO:0021670 | lateral ventricle development | 1.290384e-3 |
GO:0033326 | cerebrospinal fluid secretion | 1.305744e-3 |
GO:0043374 | CD8-positive, alpha-beta T cell differentiation | 1.371841e-3 |
GO:0048521 | negative regulation of behavior | 1.399602e-3 |
GO:0016331 | morphogenesis of embryonic epithelium | 1.408739e-3 |
GO:0001941 | postsynaptic membrane organization | 1.527977e-3 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 1.547528e-3 |
GO:0044334 | canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition | 1.567584e-3 |
GO:0010909 | positive regulation of heparan sulfate proteoglycan biosynthetic process | 1.567584e-3 |
GO:0035491 | positive regulation of leukotriene production involved in inflammatory response | 1.616538e-3 |
GO:0071258 | cellular response to gravity | 1.616538e-3 |
GO:2000098 | negative regulation of smooth muscle cell-matrix adhesion | 1.616538e-3 |
GO:0061044 | negative regulation of vascular wound healing | 1.616538e-3 |
GO:0048523 | negative regulation of cellular process | 1.647633e-3 |
GO:0042129 | regulation of T cell proliferation | 1.656875e-3 |
GO:0033260 | DNA replication involved in S phase | 1.752491e-3 |
GO:0010559 | regulation of glycoprotein biosynthetic process | 1.768180e-3 |
GO:0032623 | interleukin-2 production | 1.786871e-3 |
GO:0021591 | ventricular system development | 1.838303e-3 |
GO:0007128 | meiotic prophase I | 1.842500e-3 |
GO:0009311 | oligosaccharide metabolic process | 1.853967e-3 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 1.899461e-3 |
GO:0016051 | carbohydrate biosynthetic process | 1.916926e-3 |
GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 1.943595e-3 |
GO:0014034 | neural crest cell fate commitment | 1.975303e-3 |
GO:0002862 | negative regulation of inflammatory response to antigenic stimulus | 1.975303e-3 |
GO:0051685 | maintenance of ER location | 1.975974e-3 |
GO:0070350 | regulation of white fat cell proliferation | 1.975974e-3 |
GO:0071887 | leukocyte apoptosis | 2.078558e-3 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 2.083208e-3 |
GO:0048617 | embryonic foregut morphogenesis | 2.140768e-3 |
GO:0072070 | loop of Henle development | 2.145907e-3 |
GO:0045920 | negative regulation of exocytosis | 2.189159e-3 |
GO:0002003 | angiotensin maturation | 2.197888e-3 |
GO:0071731 | response to nitric oxide | 2.205015e-3 |
GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process | 2.279713e-3 |
GO:0040023 | establishment of nucleus localization | 2.288550e-3 |
GO:0048713 | regulation of oligodendrocyte differentiation | 2.333946e-3 |
GO:0042987 | amyloid precursor protein catabolic process | 2.337325e-3 |
GO:0035552 | oxidative single-stranded DNA demethylation | 2.434657e-3 |
GO:0072283 | metanephric renal vesicle morphogenesis | 2.567292e-3 |
GO:0000090 | mitotic anaphase | 2.732233e-3 |
GO:0003338 | metanephros morphogenesis | 2.773361e-3 |
GO:0019432 | triglyceride biosynthetic process | 2.783997e-3 |
GO:0046365 | monosaccharide catabolic process | 2.806557e-3 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.851022e-3 |
GO:0090181 | regulation of cholesterol metabolic process | 2.880630e-3 |
GO:0070849 | response to epidermal growth factor stimulus | 2.882677e-3 |
GO:0042551 | neuron maturation | 2.900225e-3 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 2.928680e-3 |
GO:0071845 | cellular component disassembly at cellular level | 2.958513e-3 |
GO:0003094 | glomerular filtration | 2.967411e-3 |
GO:0008354 | germ cell migration | 2.987402e-3 |
GO:0072337 | modified amino acid transport | 3.017210e-3 |
GO:0015825 | L-serine transport | 3.018991e-3 |
GO:0030889 | negative regulation of B cell proliferation | 3.025189e-3 |
GO:0051176 | positive regulation of sulfur metabolic process | 3.074255e-3 |
GO:0090344 | negative regulation of cell aging | 3.219145e-3 |
GO:0042776 | mitochondrial ATP synthesis coupled proton transport | 3.219145e-3 |
GO:0015742 | alpha-ketoglutarate transport | 3.237299e-3 |
GO:0042307 | positive regulation of protein import into nucleus | 3.335573e-3 |
GO:0061162 | establishment of monopolar cell polarity | 3.352457e-3 |
GO:0051324 | prophase | 3.352457e-3 |
GO:0042990 | regulation of transcription factor import into nucleus | 3.419657e-3 |
GO:0030260 | entry into host cell | 3.422727e-3 |
GO:0043968 | histone H2A acetylation | 3.442540e-3 |
GO:0042762 | regulation of sulfur metabolic process | 3.469363e-3 |
GO:0072077 | renal vesicle morphogenesis | 3.470011e-3 |
GO:0071305 | cellular response to vitamin D | 3.534453e-3 |
GO:0010605 | negative regulation of macromolecule metabolic process | 3.577012e-3 |
GO:0031214 | biomineral tissue development | 3.599632e-3 |
GO:0022411 | cellular component disassembly | 3.670989e-3 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 3.746148e-3 |
GO:2000097 | regulation of smooth muscle cell-matrix adhesion | 3.758392e-3 |
GO:0014032 | neural crest cell development | 3.806910e-3 |
GO:0046148 | pigment biosynthetic process | 3.808268e-3 |
GO:0007442 | hindgut morphogenesis | 3.860176e-3 |
GO:0090129 | positive regulation of synapse maturation | 3.899656e-3 |
GO:0046504 | glycerol ether biosynthetic process | 3.926772e-3 |
GO:0030510 | regulation of BMP signaling pathway | 3.974311e-3 |
GO:0048333 | mesodermal cell differentiation | 3.987386e-3 |
GO:0043304 | regulation of mast cell degranulation | 4.007212e-3 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 4.064420e-3 |
GO:0043009 | chordate embryonic development | 4.081437e-3 |
GO:0045807 | positive regulation of endocytosis | 4.129162e-3 |
GO:0006220 | pyrimidine nucleotide metabolic process | 4.152307e-3 |
GO:0060841 | venous blood vessel development | 4.154739e-3 |
GO:0071260 | cellular response to mechanical stimulus | 4.183287e-3 |
GO:0007130 | synaptonemal complex assembly | 4.206893e-3 |
GO:0000080 | G1 phase of mitotic cell cycle | 4.387995e-3 |
GO:0007440 | foregut morphogenesis | 4.424521e-3 |
GO:0030103 | vasopressin secretion | 4.478010e-3 |
GO:0043622 | cortical microtubule organization | 4.478010e-3 |
GO:0019303 | D-ribose catabolic process | 4.478010e-3 |
GO:0046463 | acylglycerol biosynthetic process | 4.510994e-3 |
GO:0051318 | G1 phase | 4.569124e-3 |
GO:0001525 | angiogenesis | 4.669731e-3 |
GO:0072087 | renal vesicle development | 4.687885e-3 |
GO:0000160 | two-component signal transduction system (phosphorelay) | 4.729532e-3 |
GO:0048519 | negative regulation of biological process | 4.784405e-3 |
GO:0090128 | regulation of synapse maturation | 4.872489e-3 |
GO:0010811 | positive regulation of cell-substrate adhesion | 4.883707e-3 |
GO:0051299 | centrosome separation | 4.900096e-3 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 4.948896e-3 |
GO:0051322 | anaphase | 5.069377e-3 |
GO:0014029 | neural crest formation | 5.083367e-3 |
GO:0046131 | pyrimidine ribonucleoside metabolic process | 5.103462e-3 |
GO:0035176 | social behavior | 5.172541e-3 |
GO:0031346 | positive regulation of cell projection organization | 5.197907e-3 |
GO:0002883 | regulation of hypersensitivity | 5.215554e-3 |
GO:0042094 | interleukin-2 biosynthetic process | 5.231825e-3 |
GO:0032329 | serine transport | 5.330882e-3 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 5.340637e-3 |
GO:0019748 | secondary metabolic process | 5.397328e-3 |
GO:0009437 | carnitine metabolic process | 5.418341e-3 |
GO:0007127 | meiosis I | 5.479451e-3 |
GO:0051325 | interphase | 5.481131e-3 |
GO:0006213 | pyrimidine nucleoside metabolic process | 5.584508e-3 |
GO:0071214 | cellular response to abiotic stimulus | 5.689269e-3 |
GO:0006516 | glycoprotein catabolic process | 5.733122e-3 |
GO:0009792 | embryo development ending in birth or egg hatching | 5.864152e-3 |
GO:0060993 | kidney morphogenesis | 5.924137e-3 |
GO:0002695 | negative regulation of leukocyte activation | 6.032657e-3 |
GO:0048659 | smooth muscle cell proliferation | 6.103903e-3 |
GO:0035511 | oxidative DNA demethylation | 6.103903e-3 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 6.118581e-3 |
GO:0015811 | L-cystine transport | 6.121414e-3 |
GO:0006470 | protein dephosphorylation | 6.210376e-3 |
GO:0051705 | behavioral interaction between organisms | 6.237730e-3 |
GO:0006458 | 'de novo' protein folding | 6.242458e-3 |
GO:0001824 | blastocyst development | 6.243574e-3 |
GO:0021858 | GABAergic neuron differentiation in basal ganglia | 6.401278e-3 |
GO:0006546 | glycine catabolic process | 6.401278e-3 |
GO:0072210 | metanephric nephron development | 6.437084e-3 |
GO:0048566 | embryonic digestive tract development | 6.487494e-3 |
GO:0016055 | Wnt receptor signaling pathway | 6.748526e-3 |
GO:0043149 | stress fiber assembly | 6.796254e-3 |
GO:0009163 | nucleoside biosynthetic process | 7.022118e-3 |
GO:0034764 | positive regulation of transmembrane transport | 7.171192e-3 |
GO:0001676 | long-chain fatty acid metabolic process | 7.231161e-3 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 7.273616e-3 |
GO:0007468 | regulation of rhodopsin gene expression | 7.273616e-3 |
GO:0072227 | metanephric macula densa development | 7.469329e-3 |
GO:0072240 | metanephric DCT cell differentiation | 7.469329e-3 |
GO:0002331 | pre-B cell allelic exclusion | 7.469329e-3 |
GO:0060713 | labyrinthine layer morphogenesis | 7.515002e-3 |
GO:0016044 | cellular membrane organization | 7.590166e-3 |
GO:0060612 | adipose tissue development | 7.603710e-3 |
GO:0048668 | collateral sprouting | 7.605284e-3 |
GO:0006268 | DNA unwinding involved in replication | 7.605284e-3 |
GO:0006353 | transcription termination, DNA-dependent | 7.635184e-3 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 7.657092e-3 |
GO:0014916 | regulation of lung blood pressure | 7.927925e-3 |
GO:0001701 | in utero embryonic development | 7.981068e-3 |
GO:0007159 | leukocyte cell-cell adhesion | 8.064090e-3 |
GO:0003205 | cardiac chamber development | 8.072253e-3 |
GO:0045833 | negative regulation of lipid metabolic process | 8.085812e-3 |
GO:0045665 | negative regulation of neuron differentiation | 8.087044e-3 |
GO:0061024 | membrane organization | 8.217694e-3 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 8.259415e-3 |
GO:0034378 | chylomicron assembly | 8.341254e-3 |
GO:0090026 | positive regulation of monocyte chemotaxis | 8.544085e-3 |
GO:0001946 | lymphangiogenesis | 8.544085e-3 |
GO:0021794 | thalamus development | 8.544085e-3 |
GO:0051150 | regulation of smooth muscle cell differentiation | 8.548139e-3 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 8.616509e-3 |
GO:0043300 | regulation of leukocyte degranulation | 8.672424e-3 |
GO:0019218 | regulation of steroid metabolic process | 8.710442e-3 |
GO:0014013 | regulation of gliogenesis | 8.771827e-3 |
GO:0050868 | negative regulation of T cell activation | 8.785848e-3 |
GO:0033627 | cell adhesion mediated by integrin | 8.830868e-3 |
GO:0051329 | interphase of mitotic cell cycle | 9.249801e-3 |
GO:0001756 | somitogenesis | 9.271964e-3 |
GO:0035112 | genitalia morphogenesis | 9.275351e-3 |
GO:0045814 | negative regulation of gene expression, epigenetic | 9.291322e-3 |
GO:0045162 | clustering of voltage-gated sodium channels | 9.307925e-3 |
GO:0061053 | somite development | 9.469417e-3 |
GO:0055090 | acylglycerol homeostasis | 9.474547e-3 |
GO:0006968 | cellular defense response | 9.540743e-3 |
GO:0019320 | hexose catabolic process | 9.564561e-3 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 9.577980e-3 |
GO:0042440 | pigment metabolic process | 9.647467e-3 |
GO:0007016 | cytoskeletal anchoring at plasma membrane | 9.733546e-3 |
GO:0033003 | regulation of mast cell activation | 9.736743e-3 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 9.960164e-3 |
GO:0042098 | T cell proliferation | 1.008161e-2 |
GO:0002688 | regulation of leukocyte chemotaxis | 1.013507e-2 |
GO:0014015 | positive regulation of gliogenesis | 1.022506e-2 |
GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 1.025437e-2 |
GO:0033006 | regulation of mast cell activation involved in immune response | 1.042186e-2 |
GO:0031345 | negative regulation of cell projection organization | 1.047782e-2 |
GO:0009071 | serine family amino acid catabolic process | 1.049789e-2 |
GO:0010975 | regulation of neuron projection development | 1.062383e-2 |
GO:0006487 | protein N-linked glycosylation | 1.064791e-2 |
GO:0090285 | negative regulation of protein glycosylation in Golgi | 1.067219e-2 |
GO:0000917 | barrier septum formation | 1.067219e-2 |
GO:0071407 | cellular response to organic cyclic compound | 1.069382e-2 |
GO:0072086 | specification of loop of Henle identity | 1.070327e-2 |
GO:0006177 | GMP biosynthetic process | 1.070327e-2 |
GO:0010769 | regulation of cell morphogenesis involved in differentiation | 1.097509e-2 |
GO:0060711 | labyrinthine layer development | 1.110557e-2 |
GO:0046532 | regulation of photoreceptor cell differentiation | 1.110775e-2 |
GO:0001300 | chronological cell aging | 1.124091e-2 |
GO:0080111 | DNA demethylation | 1.174132e-2 |
GO:0030282 | bone mineralization | 1.183044e-2 |
GO:0090130 | tissue migration | 1.189049e-2 |
GO:0014033 | neural crest cell differentiation | 1.191900e-2 |
GO:0072657 | protein localization in membrane | 1.194565e-2 |
GO:0007276 | gamete generation | 1.234865e-2 |
GO:0001738 | morphogenesis of a polarized epithelium | 1.238467e-2 |
GO:0001964 | startle response | 1.247089e-2 |
GO:0016571 | histone methylation | 1.250238e-2 |
GO:0070560 | protein secretion by platelet | 1.257899e-2 |
GO:0060305 | regulation of cell diameter | 1.257899e-2 |
GO:0010920 | negative regulation of inositol phosphate biosynthetic process | 1.257899e-2 |
GO:0010925 | positive regulation of inositol-polyphosphate 5-phosphatase activity | 1.257899e-2 |
GO:0030845 | inhibition of phospholipase C activity involved in G-protein coupled receptor signaling pathway | 1.257899e-2 |
GO:0006206 | pyrimidine base metabolic process | 1.262170e-2 |
GO:0048514 | blood vessel morphogenesis | 1.267114e-2 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 1.280440e-2 |
GO:0014912 | negative regulation of smooth muscle cell migration | 1.284955e-2 |
GO:0060438 | trachea development | 1.323668e-2 |
GO:0010189 | vitamin E biosynthetic process | 1.325536e-2 |
GO:0019323 | pentose catabolic process | 1.325536e-2 |
GO:0051643 | endoplasmic reticulum localization | 1.392719e-2 |
GO:0003231 | cardiac ventricle development | 1.406292e-2 |
GO:0035710 | CD4-positive, alpha-beta T cell activation | 1.412605e-2 |
GO:0003002 | regionalization | 1.426914e-2 |
GO:0006072 | glycerol-3-phosphate metabolic process | 1.435379e-2 |
GO:0050671 | positive regulation of lymphocyte proliferation | 1.441642e-2 |
GO:0072233 | metanephric thick ascending limb development | 1.463084e-2 |
GO:0070316 | regulation of G0 to G1 transition | 1.463084e-2 |
GO:0072218 | metanephric ascending thin limb development | 1.463084e-2 |
GO:0047484 | regulation of response to osmotic stress | 1.463837e-2 |
GO:0032913 | negative regulation of transforming growth factor beta3 production | 1.463837e-2 |
GO:0032600 | chemokine receptor transport out of membrane raft | 1.463837e-2 |
GO:0032597 | B cell receptor transport into membrane raft | 1.463837e-2 |
GO:0046164 | alcohol catabolic process | 1.469375e-2 |
GO:0035282 | segmentation | 1.469388e-2 |
GO:0046825 | regulation of protein export from nucleus | 1.472600e-2 |
GO:0035024 | negative regulation of Rho protein signal transduction | 1.486806e-2 |
GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process | 1.487206e-2 |
GO:0006094 | gluconeogenesis | 1.497582e-2 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 1.527841e-2 |
GO:0097091 | synaptic vesicle clustering | 1.533345e-2 |
GO:0035524 | proline transmembrane transport | 1.533345e-2 |
GO:0032808 | lacrimal gland development | 1.533345e-2 |
GO:0003208 | cardiac ventricle morphogenesis | 1.533803e-2 |
GO:0042982 | amyloid precursor protein metabolic process | 1.541150e-2 |
GO:0072006 | nephron development | 1.556411e-2 |
GO:0043967 | histone H4 acetylation | 1.568022e-2 |
GO:0021756 | striatum development | 1.625287e-2 |
GO:0072527 | pyrimidine-containing compound metabolic process | 1.659910e-2 |
GO:0048598 | embryonic morphogenesis | 1.666239e-2 |
GO:0097114 | N-methyl-D-aspartate receptor clustering | 1.686071e-2 |
GO:0097117 | guanylate kinase-associated protein clustering | 1.686071e-2 |
GO:0032512 | regulation of protein phosphatase type 2B activity | 1.686071e-2 |
GO:0097112 | gamma-aminobutyric acid receptor clustering | 1.686071e-2 |
GO:0010350 | cellular response to magnesium starvation | 1.686071e-2 |
GO:0045835 | negative regulation of meiosis | 1.688014e-2 |
GO:0046949 | fatty-acyl-CoA biosynthetic process | 1.688443e-2 |
GO:0003197 | endocardial cushion development | 1.706274e-2 |
GO:0042304 | regulation of fatty acid biosynthetic process | 1.718841e-2 |
GO:0030300 | regulation of intestinal cholesterol absorption | 1.741653e-2 |
GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 1.758106e-2 |
GO:0001805 | positive regulation of type III hypersensitivity | 1.758106e-2 |
GO:0070534 | protein K63-linked ubiquitination | 1.759741e-2 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 1.764266e-2 |
GO:0033578 | protein glycosylation in Golgi | 1.764381e-2 |
GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 1.770925e-2 |
GO:0050866 | negative regulation of cell activation | 1.781692e-2 |
GO:0003382 | epithelial cell morphogenesis | 1.788659e-2 |
GO:0006098 | pentose-phosphate shunt | 1.823114e-2 |
GO:0002683 | negative regulation of immune system process | 1.839857e-2 |
GO:0006382 | adenosine to inosine editing | 1.844687e-2 |
GO:0051754 | meiotic sister chromatid cohesion, centromeric | 1.847461e-2 |
GO:0015808 | L-alanine transport | 1.852090e-2 |
GO:0043097 | pyrimidine nucleoside salvage | 1.857302e-2 |
GO:0002685 | regulation of leukocyte migration | 1.866317e-2 |
GO:0006915 | apoptosis | 1.877027e-2 |
GO:0030203 | glycosaminoglycan metabolic process | 1.890852e-2 |
GO:0048625 | myoblast cell fate commitment | 1.901511e-2 |
GO:0042360 | vitamin E metabolic process | 1.913831e-2 |
GO:0060134 | prepulse inhibition | 1.929177e-2 |
GO:0008624 | induction of apoptosis by extracellular signals | 1.947485e-2 |
GO:0019953 | sexual reproduction | 1.955928e-2 |
GO:0072348 | sulfur compound transport | 1.966772e-2 |
GO:0014824 | artery smooth muscle contraction | 1.966772e-2 |
GO:0048286 | lung alveolus development | 1.973829e-2 |
GO:0021915 | neural tube development | 1.975719e-2 |
GO:0010469 | regulation of receptor activity | 1.978321e-2 |
GO:0090183 | regulation of kidney development | 1.992253e-2 |
GO:0050728 | negative regulation of inflammatory response | 2.011953e-2 |
GO:0033059 | cellular pigmentation | 2.030692e-2 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 2.036982e-2 |
GO:0051388 | positive regulation of nerve growth factor receptor signaling pathway | 2.075126e-2 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 2.075974e-2 |
GO:0031016 | pancreas development | 2.076455e-2 |
GO:0051647 | nucleus localization | 2.121672e-2 |
GO:0006921 | cellular component disassembly involved in apoptosis | 2.145991e-2 |
GO:0043982 | histone H4-K8 acetylation | 2.146843e-2 |
GO:0043981 | histone H4-K5 acetylation | 2.146843e-2 |
GO:0006688 | glycosphingolipid biosynthetic process | 2.162892e-2 |
GO:0006386 | termination of RNA polymerase III transcription | 2.181289e-2 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 2.181289e-2 |
GO:0051382 | kinetochore assembly | 2.185923e-2 |
GO:0060221 | retinal rod cell differentiation | 2.185923e-2 |
GO:0007099 | centriole replication | 2.185923e-2 |
GO:0043900 | regulation of multi-organism process | 2.189483e-2 |
GO:0045922 | negative regulation of fatty acid metabolic process | 2.207068e-2 |
GO:0042273 | ribosomal large subunit biogenesis | 2.209031e-2 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.243474e-2 |
GO:0050767 | regulation of neurogenesis | 2.251824e-2 |
GO:0035510 | DNA dealkylation | 2.280166e-2 |
GO:0048708 | astrocyte differentiation | 2.326539e-2 |
GO:0072132 | mesenchyme morphogenesis | 2.343703e-2 |
GO:0072081 | specification of nephron tubule identity | 2.368562e-2 |
GO:0009112 | nucleobase metabolic process | 2.384752e-2 |
GO:0048585 | negative regulation of response to stimulus | 2.395151e-2 |
GO:0021930 | cerebellar granule cell precursor proliferation | 2.413958e-2 |
GO:0048203 | vesicle targeting, trans-Golgi to endosome | 2.413958e-2 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 2.428390e-2 |
GO:0006772 | thiamine metabolic process | 2.462886e-2 |
GO:0001839 | neural plate morphogenesis | 2.468711e-2 |
GO:0006740 | NADPH regeneration | 2.506063e-2 |
GO:0060710 | chorio-allantoic fusion | 2.506063e-2 |
GO:0016071 | mRNA metabolic process | 2.520240e-2 |
GO:0070665 | positive regulation of leukocyte proliferation | 2.521804e-2 |
GO:0044065 | regulation of respiratory system process | 2.539899e-2 |
GO:0051383 | kinetochore organization | 2.559211e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0042696 | menarche | 2.593722e-8 |
GO:0021930 | cerebellar granule cell precursor proliferation | 3.780406e-8 |
GO:0021759 | globus pallidus development | 4.014833e-8 |
GO:0006972 | hyperosmotic response | 5.232301e-8 |
GO:0048143 | astrocyte activation | 7.347784e-8 |
GO:0018364 | peptidyl-glutamine methylation | 1.531085e-7 |
GO:0008615 | pyridoxine biosynthetic process | 1.531085e-7 |
GO:0022601 | menstrual cycle phase | 1.638727e-7 |
GO:0033578 | protein glycosylation in Golgi | 2.477845e-7 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 5.259662e-7 |
GO:0021568 | rhombomere 2 development | 5.767448e-7 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 6.346131e-7 |
GO:0042538 | hyperosmotic salinity response | 1.024812e-6 |
GO:0006597 | spermine biosynthetic process | 1.038267e-6 |
GO:2000678 | negative regulation of transcription regulatory region DNA binding | 1.249845e-6 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 1.870587e-6 |
GO:0006270 | DNA-dependent DNA replication initiation | 1.870587e-6 |
GO:0060510 | Type II pneumocyte differentiation | 1.994898e-6 |
GO:0048343 | paraxial mesodermal cell fate commitment | 2.394625e-6 |
GO:0000237 | leptotene | 2.677741e-6 |
GO:0021707 | cerebellar granule cell differentiation | 2.910005e-6 |
GO:0006970 | response to osmotic stress | 3.139685e-6 |
GO:0060430 | lung saccule development | 3.192840e-6 |
GO:0045014 | negative regulation of transcription by glucose | 3.545296e-6 |
GO:0021683 | cerebellar granular layer morphogenesis | 4.847400e-6 |
GO:0021953 | central nervous system neuron differentiation | 5.375423e-6 |
GO:0042063 | gliogenesis | 5.519961e-6 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 5.712449e-6 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 5.804055e-6 |
GO:0007631 | feeding behavior | 5.866048e-6 |
GO:0060486 | Clara cell differentiation | 6.097370e-6 |
GO:0006352 | transcription initiation, DNA-dependent | 7.361952e-6 |
GO:0010001 | glial cell differentiation | 7.389240e-6 |
GO:0060075 | regulation of resting membrane potential | 8.726091e-6 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 9.484707e-6 |
GO:2000224 | regulation of testosterone biosynthetic process | 1.421135e-5 |
GO:0021681 | cerebellar granular layer development | 1.795877e-5 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 1.940822e-5 |
GO:0046883 | regulation of hormone secretion | 1.975024e-5 |
GO:0032808 | lacrimal gland development | 2.095282e-5 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 2.095282e-5 |
GO:0033327 | Leydig cell differentiation | 2.207299e-5 |
GO:0046015 | regulation of transcription by glucose | 2.298673e-5 |
GO:0006465 | signal peptide processing | 3.060282e-5 |
GO:0014034 | neural crest cell fate commitment | 3.169185e-5 |
GO:0048680 | positive regulation of axon regeneration | 3.354907e-5 |
GO:0008343 | adult feeding behavior | 3.354907e-5 |
GO:0006268 | DNA unwinding involved in replication | 3.671863e-5 |
GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 4.012384e-5 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 4.176410e-5 |
GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway | 4.377745e-5 |
GO:0046668 | regulation of retinal cell programmed cell death | 4.377745e-5 |
GO:0045136 | development of secondary sexual characteristics | 4.504182e-5 |
GO:0030878 | thyroid gland development | 5.161588e-5 |
GO:0046543 | development of secondary female sexual characteristics | 5.244858e-5 |
GO:0046600 | negative regulation of centriole replication | 5.454881e-5 |
GO:0006596 | polyamine biosynthetic process | 6.537174e-5 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling pathway | 7.170286e-5 |
GO:0021546 | rhombomere development | 8.361989e-5 |
GO:0060487 | lung epithelial cell differentiation | 8.627571e-5 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 9.015358e-5 |
GO:0061386 | closure of optic fissure | 9.015874e-5 |
GO:0035332 | positive regulation of hippo signaling cascade | 9.015874e-5 |
GO:0006233 | dTDP biosynthetic process | 9.015874e-5 |
GO:0021877 | forebrain neuron fate commitment | 9.056588e-5 |
GO:0008215 | spermine metabolic process | 9.218911e-5 |
GO:0046533 | negative regulation of photoreceptor cell differentiation | 1.122227e-4 |
GO:0048679 | regulation of axon regeneration | 1.203458e-4 |
GO:0001946 | lymphangiogenesis | 1.204616e-4 |
GO:0060479 | lung cell differentiation | 1.213438e-4 |
GO:0060218 | hemopoietic stem cell differentiation | 1.337506e-4 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 1.342850e-4 |
GO:0060023 | soft palate development | 1.383759e-4 |
GO:0014002 | astrocyte development | 1.417295e-4 |
GO:0032508 | DNA duplex unwinding | 1.480903e-4 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 1.480903e-4 |
GO:0014029 | neural crest formation | 1.608207e-4 |
GO:0001945 | lymph vessel development | 1.643393e-4 |
GO:0032392 | DNA geometric change | 1.691346e-4 |
GO:0014032 | neural crest cell development | 1.704923e-4 |
GO:0009138 | pyrimidine nucleoside diphosphate metabolic process | 1.758304e-4 |
GO:0021697 | cerebellar cortex formation | 1.835577e-4 |
GO:0070884 | regulation of calcineurin-NFAT signaling pathway | 1.837765e-4 |
GO:0021555 | midbrain-hindbrain boundary morphogenesis | 2.050561e-4 |
GO:0045930 | negative regulation of mitotic cell cycle | 2.123131e-4 |
GO:0060563 | neuroepithelial cell differentiation | 2.141417e-4 |
GO:0014009 | glial cell proliferation | 2.194939e-4 |
GO:0048709 | oligodendrocyte differentiation | 2.209085e-4 |
GO:0006302 | double-strand break repair | 2.279676e-4 |
GO:0046545 | development of primary female sexual characteristics | 2.401277e-4 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 2.479684e-4 |
GO:0070669 | response to interleukin-2 | 2.484027e-4 |
GO:0021533 | cell differentiation in hindbrain | 2.489857e-4 |
GO:0045665 | negative regulation of neuron differentiation | 2.567620e-4 |
GO:0006974 | response to DNA damage stimulus | 2.730285e-4 |
GO:0019835 | cytolysis | 3.141292e-4 |
GO:0048708 | astrocyte differentiation | 3.256474e-4 |
GO:0003357 | noradrenergic neuron differentiation | 3.285041e-4 |
GO:0046532 | regulation of photoreceptor cell differentiation | 3.307114e-4 |
GO:0035330 | regulation of hippo signaling cascade | 3.376746e-4 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 3.499075e-4 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 3.537022e-4 |
GO:0060425 | lung morphogenesis | 3.634642e-4 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 4.287947e-4 |
GO:0007076 | mitotic chromosome condensation | 4.355666e-4 |
GO:0061029 | eyelid development in camera-type eye | 4.396763e-4 |
GO:2000677 | regulation of transcription regulatory region DNA binding | 4.558315e-4 |
GO:0006281 | DNA repair | 5.335604e-4 |
GO:0021895 | cerebral cortex neuron differentiation | 5.439899e-4 |
GO:0010948 | negative regulation of cell cycle process | 5.736103e-4 |
GO:0006595 | polyamine metabolic process | 5.928434e-4 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 6.031805e-4 |
GO:0000724 | double-strand break repair via homologous recombination | 6.674637e-4 |
GO:0033002 | muscle cell proliferation | 6.750095e-4 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 6.951384e-4 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 7.371557e-4 |
GO:0060022 | hard palate development | 7.568106e-4 |
GO:0046599 | regulation of centriole replication | 7.838941e-4 |
GO:0046660 | female sex differentiation | 7.903230e-4 |
GO:0000725 | recombinational repair | 8.125840e-4 |
GO:0060441 | epithelial tube branching involved in lung morphogenesis | 8.175277e-4 |
GO:0048333 | mesodermal cell differentiation | 8.390597e-4 |
GO:0032856 | activation of Ras GTPase activity | 8.717777e-4 |
GO:0046887 | positive regulation of hormone secretion | 8.752918e-4 |
GO:0008283 | cell proliferation | 9.014300e-4 |
GO:0031128 | developmental induction | 9.138698e-4 |
GO:0042476 | odontogenesis | 9.552523e-4 |
GO:0017158 | regulation of calcium ion-dependent exocytosis | 9.995669e-4 |
GO:0071474 | cellular hyperosmotic response | 1.041434e-3 |
GO:0042475 | odontogenesis of dentine-containing tooth | 1.069996e-3 |
GO:0060038 | cardiac muscle cell proliferation | 1.087223e-3 |
GO:0009133 | nucleoside diphosphate biosynthetic process | 1.088200e-3 |
GO:0007141 | male meiosis I | 1.088200e-3 |
GO:0009651 | response to salt stress | 1.097725e-3 |
GO:0060052 | neurofilament cytoskeleton organization | 1.137278e-3 |
GO:0035928 | rRNA import into mitochondrion | 1.197258e-3 |
GO:0009992 | cellular water homeostasis | 1.197258e-3 |
GO:0022602 | ovulation cycle process | 1.229678e-3 |
GO:0014033 | neural crest cell differentiation | 1.252437e-3 |
GO:0060428 | lung epithelium development | 1.278706e-3 |
GO:0050886 | endocrine process | 1.303457e-3 |
GO:0060081 | membrane hyperpolarization | 1.398630e-3 |
GO:0006220 | pyrimidine nucleotide metabolic process | 1.404010e-3 |
GO:0070634 | transepithelial ammonium transport | 1.493705e-3 |
GO:0045168 | cell-cell signaling involved in cell fate commitment | 1.544560e-3 |
GO:0048245 | eosinophil chemotaxis | 1.551158e-3 |
GO:0021696 | cerebellar cortex morphogenesis | 1.630479e-3 |
GO:0021782 | glial cell development | 1.697082e-3 |
GO:0055017 | cardiac muscle tissue growth | 1.709713e-3 |
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 1.750109e-3 |
GO:0006012 | galactose metabolic process | 1.750381e-3 |
GO:0051797 | regulation of hair follicle development | 1.777397e-3 |
GO:0007213 | muscarinic acetylcholine receptor signaling pathway | 1.847093e-3 |
GO:0030311 | poly-N-acetyllactosamine biosynthetic process | 1.885301e-3 |
GO:0050849 | negative regulation of calcium-mediated signaling | 1.964281e-3 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 2.135639e-3 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 2.194072e-3 |
GO:0048341 | paraxial mesoderm formation | 2.225578e-3 |
GO:0050798 | activated T cell proliferation | 2.258292e-3 |
GO:0043403 | skeletal muscle tissue regeneration | 2.327459e-3 |
GO:0007417 | central nervous system development | 2.434140e-3 |
GO:0070253 | somatostatin secretion | 2.497685e-3 |
GO:0042703 | menstruation | 2.497685e-3 |
GO:0015739 | sialic acid transport | 2.497685e-3 |
GO:0032812 | positive regulation of epinephrine secretion | 2.497685e-3 |
GO:0019101 | female somatic sex determination | 2.497685e-3 |
GO:0071779 | G1/S transition checkpoint | 2.620025e-3 |
GO:0060419 | heart growth | 2.663142e-3 |
GO:0021871 | forebrain regionalization | 2.679371e-3 |
GO:0048483 | autonomic nervous system development | 2.716006e-3 |
GO:0042698 | ovulation cycle | 2.729584e-3 |
GO:0000082 | G1/S transition of mitotic cell cycle | 2.805696e-3 |
GO:0006544 | glycine metabolic process | 2.912183e-3 |
GO:0019087 | transformation of host cell by virus | 2.980879e-3 |
GO:0061303 | cornea development in camera-type eye | 3.039936e-3 |
GO:0015724 | formate transport | 3.190823e-3 |
GO:0090231 | regulation of spindle checkpoint | 3.251066e-3 |
GO:0009262 | deoxyribonucleotide metabolic process | 3.291102e-3 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 3.308442e-3 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 3.441695e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 3.489901e-3 |
GO:0035265 | organ growth | 3.671335e-3 |
GO:0007128 | meiotic prophase I | 3.723429e-3 |
GO:0007259 | JAK-STAT cascade | 3.909901e-3 |
GO:0071104 | response to interleukin-9 | 3.963104e-3 |
GO:0019402 | galactitol metabolic process | 3.963104e-3 |
GO:0007250 | activation of NF-kappaB-inducing kinase activity | 3.968345e-3 |
GO:0090304 | nucleic acid metabolic process | 4.080583e-3 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 4.095176e-3 |
GO:0043374 | CD8-positive, alpha-beta T cell differentiation | 4.193703e-3 |
GO:0060174 | limb bud formation | 4.240578e-3 |
GO:0042218 | 1-aminocyclopropane-1-carboxylate biosynthetic process | 4.269953e-3 |
GO:0006518 | peptide metabolic process | 4.270368e-3 |
GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 4.290182e-3 |
GO:0022008 | neurogenesis | 4.343965e-3 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 4.377678e-3 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.472778e-3 |
GO:0042634 | regulation of hair cycle | 4.493658e-3 |
GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 4.548474e-3 |
GO:0045683 | negative regulation of epidermis development | 4.632618e-3 |
GO:0051124 | synaptic growth at neuromuscular junction | 4.637121e-3 |
GO:0046007 | negative regulation of activated T cell proliferation | 4.637121e-3 |
GO:0032861 | activation of Rap GTPase activity | 4.637121e-3 |
GO:0035412 | regulation of catenin import into nucleus | 4.650100e-3 |
GO:0021587 | cerebellum morphogenesis | 4.705763e-3 |
GO:0015696 | ammonium transport | 4.746721e-3 |
GO:0070093 | negative regulation of glucagon secretion | 4.812943e-3 |
GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | 4.904186e-3 |
GO:0009132 | nucleoside diphosphate metabolic process | 4.927365e-3 |
GO:0006767 | water-soluble vitamin metabolic process | 5.142950e-3 |
GO:0051253 | negative regulation of RNA metabolic process | 5.160601e-3 |
GO:0051046 | regulation of secretion | 5.171966e-3 |
GO:0051645 | Golgi localization | 5.246316e-3 |
GO:0010721 | negative regulation of cell development | 5.433609e-3 |
GO:0050847 | progesterone receptor signaling pathway | 5.474077e-3 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5.550879e-3 |
GO:0048699 | generation of neurons | 5.578969e-3 |
GO:0006710 | androgen catabolic process | 5.738777e-3 |
GO:0034626 | fatty acid elongation, polyunsaturated fatty acid | 5.779899e-3 |
GO:0045596 | negative regulation of cell differentiation | 5.932472e-3 |
GO:0009069 | serine family amino acid metabolic process | 5.954414e-3 |
GO:0030902 | hindbrain development | 5.970770e-3 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 5.999799e-3 |
GO:0034625 | fatty acid elongation, monounsaturated fatty acid | 6.059742e-3 |
GO:0072657 | protein localization in membrane | 6.167242e-3 |
GO:0060341 | regulation of cellular localization | 6.201348e-3 |
GO:0090278 | negative regulation of peptide hormone secretion | 6.306121e-3 |
GO:0006259 | DNA metabolic process | 6.455477e-3 |
GO:0045577 | regulation of B cell differentiation | 6.585959e-3 |
GO:0021549 | cerebellum development | 6.726623e-3 |
GO:0018993 | somatic sex determination | 6.739064e-3 |
GO:0060251 | regulation of glial cell proliferation | 6.739399e-3 |
GO:0021879 | forebrain neuron differentiation | 6.968895e-3 |
GO:0070534 | protein K63-linked ubiquitination | 7.017717e-3 |
GO:0007140 | male meiosis | 7.116306e-3 |
GO:0032859 | activation of Ral GTPase activity | 7.237235e-3 |
GO:0061072 | iris morphogenesis | 7.237235e-3 |
GO:0051795 | positive regulation of catagen | 7.237235e-3 |
GO:0000726 | non-recombinational repair | 7.268881e-3 |
GO:2000648 | positive regulation of stem cell proliferation | 7.462129e-3 |
GO:0001710 | mesodermal cell fate commitment | 7.462129e-3 |
GO:0032925 | regulation of activin receptor signaling pathway | 7.462129e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 7.508213e-3 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 7.566278e-3 |
GO:0051297 | centrosome organization | 7.618130e-3 |
GO:0048818 | positive regulation of hair follicle maturation | 7.738837e-3 |
GO:0006433 | prolyl-tRNA aminoacylation | 7.812288e-3 |
GO:0060018 | astrocyte fate commitment | 7.928906e-3 |
GO:0006887 | exocytosis | 8.038795e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 8.076749e-3 |
GO:0030182 | neuron differentiation | 8.181212e-3 |
GO:0042364 | water-soluble vitamin biosynthetic process | 8.223487e-3 |
GO:0006261 | DNA-dependent DNA replication | 8.235979e-3 |
GO:0035413 | positive regulation of catenin import into nucleus | 8.273168e-3 |
GO:0021575 | hindbrain morphogenesis | 8.300554e-3 |
GO:0010824 | regulation of centrosome duplication | 8.627072e-3 |
GO:0006351 | transcription, DNA-dependent | 8.666279e-3 |
GO:0048048 | embryonic eye morphogenesis | 8.697786e-3 |
GO:0045578 | negative regulation of B cell differentiation | 8.802266e-3 |
GO:0060253 | negative regulation of glial cell proliferation | 9.037038e-3 |
GO:0002063 | chondrocyte development | 9.037038e-3 |
GO:0032774 | RNA biosynthetic process | 9.050381e-3 |
GO:0051029 | rRNA transport | 9.364419e-3 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 9.364419e-3 |
GO:0006310 | DNA recombination | 9.408153e-3 |
GO:0071800 | podosome assembly | 9.632616e-3 |
GO:0014031 | mesenchymal cell development | 9.698045e-3 |
GO:0060279 | positive regulation of ovulation | 9.947065e-3 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 9.968752e-3 |
GO:0001541 | ovarian follicle development | 1.002359e-2 |
GO:0046511 | sphinganine biosynthetic process | 1.017159e-2 |
GO:0006059 | hexitol metabolic process | 1.017159e-2 |
GO:0043114 | regulation of vascular permeability | 1.019263e-2 |
GO:0050433 | regulation of catecholamine secretion | 1.044338e-2 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 1.054476e-2 |
GO:0042487 | regulation of odontogenesis of dentine-containing tooth | 1.055034e-2 |
GO:0032147 | activation of protein kinase activity | 1.057054e-2 |
GO:0009059 | macromolecule biosynthetic process | 1.060870e-2 |
GO:0002792 | negative regulation of peptide secretion | 1.090665e-2 |
GO:0010556 | regulation of macromolecule biosynthetic process | 1.094170e-2 |
GO:0006355 | regulation of transcription, DNA-dependent | 1.101162e-2 |
GO:0015891 | siderophore transport | 1.145473e-2 |
GO:0071985 | multivesicular body sorting pathway | 1.145473e-2 |
GO:0016139 | glycoside catabolic process | 1.145473e-2 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 1.159901e-2 |
GO:0043535 | regulation of blood vessel endothelial cell migration | 1.169514e-2 |
GO:0008015 | blood circulation | 1.176696e-2 |
GO:0071470 | cellular response to osmotic stress | 1.181928e-2 |
GO:0051799 | negative regulation of hair follicle development | 1.181928e-2 |
GO:0006308 | DNA catabolic process | 1.222010e-2 |
GO:0046718 | entry of virus into host cell | 1.248517e-2 |
GO:0042701 | progesterone secretion | 1.248517e-2 |
GO:0022037 | metencephalon development | 1.253404e-2 |
GO:0010467 | gene expression | 1.279954e-2 |
GO:0030237 | female sex determination | 1.280497e-2 |
GO:0045165 | cell fate commitment | 1.304773e-2 |
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 1.308607e-2 |
GO:0061113 | pancreas morphogenesis | 1.317214e-2 |
GO:0021903 | rostrocaudal neural tube patterning | 1.380178e-2 |
GO:0048754 | branching morphogenesis of a tube | 1.381065e-2 |
GO:0019059 | initiation of viral infection | 1.388027e-2 |
GO:0019368 | fatty acid elongation, unsaturated fatty acid | 1.414946e-2 |
GO:0051252 | regulation of RNA metabolic process | 1.418162e-2 |
GO:0060879 | semicircular canal fusion | 1.422088e-2 |
GO:0061115 | lung proximal/distal axis specification | 1.422088e-2 |
GO:0060661 | submandibular salivary gland formation | 1.422088e-2 |
GO:0070352 | positive regulation of white fat cell proliferation | 1.422088e-2 |
GO:0070075 | tear secretion | 1.422088e-2 |
GO:0006424 | glutamyl-tRNA aminoacylation | 1.422088e-2 |
GO:0050674 | urothelial cell proliferation | 1.422088e-2 |
GO:0050677 | positive regulation of urothelial cell proliferation | 1.422088e-2 |
GO:0060496 | mesenchymal-epithelial cell signaling involved in lung development | 1.422088e-2 |
GO:0060436 | bronchiole morphogenesis | 1.422088e-2 |
GO:0010739 | positive regulation of protein kinase A signaling cascade | 1.460965e-2 |
GO:0008272 | sulfate transport | 1.464826e-2 |
GO:0032312 | regulation of ARF GTPase activity | 1.509616e-2 |
GO:0006413 | translational initiation | 1.529245e-2 |
GO:0070244 | negative regulation of thymocyte apoptosis | 1.536035e-2 |
GO:0001553 | luteinization | 1.550422e-2 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 1.550422e-2 |
GO:0035880 | embryonic nail plate morphogenesis | 1.570108e-2 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 1.595752e-2 |
GO:0000278 | mitotic cell cycle | 1.599942e-2 |
GO:0031076 | embryonic camera-type eye development | 1.613503e-2 |
GO:0001539 | ciliary or flagellar motility | 1.621082e-2 |
GO:0071103 | DNA conformation change | 1.629752e-2 |
GO:0031326 | regulation of cellular biosynthetic process | 1.631141e-2 |
GO:0021954 | central nervous system neuron development | 1.634179e-2 |
GO:0060004 | reflex | 1.638300e-2 |
GO:0021983 | pituitary gland development | 1.651398e-2 |
GO:0048870 | cell motility | 1.655539e-2 |
GO:0070672 | response to interleukin-15 | 1.692594e-2 |
GO:0048762 | mesenchymal cell differentiation | 1.700579e-2 |
GO:0000132 | establishment of mitotic spindle orientation | 1.717682e-2 |
GO:0031327 | negative regulation of cellular biosynthetic process | 1.723747e-2 |
GO:0001763 | morphogenesis of a branching structure | 1.769967e-2 |
GO:0032095 | regulation of response to food | 1.787402e-2 |
GO:0006584 | catecholamine metabolic process | 1.792275e-2 |
GO:0061138 | morphogenesis of a branching epithelium | 1.816642e-2 |
GO:0009890 | negative regulation of biosynthetic process | 1.821044e-2 |
GO:0046605 | regulation of centrosome cycle | 1.845108e-2 |
GO:0035434 | copper ion transmembrane transport | 1.857745e-2 |
GO:0030260 | entry into host cell | 1.857745e-2 |
GO:0019388 | galactose catabolic process | 1.884890e-2 |
GO:0048340 | paraxial mesoderm morphogenesis | 1.896473e-2 |
GO:0051093 | negative regulation of developmental process | 1.911044e-2 |
GO:0001731 | formation of translation preinitiation complex | 1.917253e-2 |
GO:0003018 | vascular process in circulatory system | 1.917735e-2 |
GO:0040001 | establishment of mitotic spindle localization | 1.943006e-2 |
GO:0009889 | regulation of biosynthetic process | 1.959753e-2 |
GO:0043392 | negative regulation of DNA binding | 1.968224e-2 |
GO:0060900 | embryonic camera-type eye formation | 1.990281e-2 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 2.020081e-2 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 2.031514e-2 |
GO:0016070 | RNA metabolic process | 2.063889e-2 |
GO:0015701 | bicarbonate transport | 2.087422e-2 |
GO:0010629 | negative regulation of gene expression | 2.130182e-2 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.162510e-2 |
GO:0048246 | macrophage chemotaxis | 2.213917e-2 |
GO:0032854 | positive regulation of Rap GTPase activity | 2.213917e-2 |
GO:0008585 | female gonad development | 2.247316e-2 |
GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.287847e-2 |
GO:0008354 | germ cell migration | 2.307632e-2 |
GO:0072659 | protein localization in plasma membrane | 2.348364e-2 |
GO:0000041 | transition metal ion transport | 2.384027e-2 |
GO:0048858 | cell projection morphogenesis | 2.388594e-2 |
GO:0031023 | microtubule organizing center organization | 2.398032e-2 |
GO:0070166 | enamel mineralization | 2.401925e-2 |
GO:0032100 | positive regulation of appetite | 2.401925e-2 |
GO:0021695 | cerebellar cortex development | 2.406926e-2 |
GO:0050769 | positive regulation of neurogenesis | 2.412520e-2 |
GO:0045161 | neuronal ion channel clustering | 2.416546e-2 |
GO:0021955 | central nervous system neuron axonogenesis | 2.432791e-2 |
GO:0003013 | circulatory system process | 2.455880e-2 |
GO:0070633 | transepithelial transport | 2.485914e-2 |
GO:0031532 | actin cytoskeleton reorganization | 2.502383e-2 |
GO:0002051 | osteoblast fate commitment | 2.503714e-2 |
GO:0034453 | microtubule anchoring | 2.504732e-2 |
GO:0061039 | ovum-producing ovary development | 2.565945e-2 |
GO:0016079 | synaptic vesicle exocytosis | 2.575356e-2 |
GO:0070384 | Harderian gland development | 2.585716e-2 |
GO:0070092 | regulation of glucagon secretion | 2.585716e-2 |
GO:0009946 | proximal/distal axis specification | 2.585716e-2 |
GO:0032922 | circadian regulation of gene expression | 2.604627e-2 |
GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein | 2.627698e-2 |
GO:0071397 | cellular response to cholesterol | 2.707693e-2 |
GO:0060693 | regulation of branching involved in salivary gland morphogenesis | 2.732244e-2 |
GO:0042733 | embryonic digit morphogenesis | 2.748709e-2 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 2.775021e-2 |
GO:0032109 | positive regulation of response to nutrient levels | 2.775021e-2 |
GO:0045162 | clustering of voltage-gated sodium channels | 2.775021e-2 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 2.775324e-2 |
GO:0046888 | negative regulation of hormone secretion | 2.780496e-2 |
GO:0060638 | mesenchymal-epithelial cell signaling | 2.791103e-2 |
GO:0006829 | zinc ion transport | 2.826382e-2 |
GO:0051954 | positive regulation of amine transport | 2.850677e-2 |
GO:0072091 | regulation of stem cell proliferation | 2.850760e-2 |
GO:0050796 | regulation of insulin secretion | 2.880943e-2 |
GO:0048863 | stem cell differentiation | 2.883443e-2 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 2.911219e-2 |
GO:0014061 | regulation of norepinephrine secretion | 2.920271e-2 |
GO:0033554 | cellular response to stress | 2.927127e-2 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.929052e-2 |
GO:0032990 | cell part morphogenesis | 2.961185e-2 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 2.969716e-2 |
GO:0006106 | fumarate metabolic process | 2.969716e-2 |
GO:0010468 | regulation of gene expression | 3.000831e-2 |
GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 3.004134e-2 |
GO:0042325 | regulation of phosphorylation | 3.027283e-2 |
GO:0048511 | rhythmic process | 3.061819e-2 |
GO:0009953 | dorsal/ventral pattern formation | 3.087040e-2 |
GO:0046880 | regulation of follicle-stimulating hormone secretion | 3.141417e-2 |
GO:0007127 | meiosis I | 3.169964e-2 |
GO:0002089 | lens morphogenesis in camera-type eye | 3.169964e-2 |
GO:0007411 | axon guidance | 3.315504e-2 |
GO:0021872 | forebrain generation of neurons | 3.340621e-2 |
GO:0048666 | neuron development | 3.349500e-2 |
GO:0007000 | nucleolus organization | 3.374793e-2 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 3.374793e-2 |
GO:0002074 | extraocular skeletal muscle development | 3.374793e-2 |
GO:0048596 | embryonic camera-type eye morphogenesis | 3.375845e-2 |
GO:0035710 | CD4-positive, alpha-beta T cell activation | 3.381857e-2 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 3.435106e-2 |
GO:0051293 | establishment of spindle localization | 3.491813e-2 |
GO:0045588 | positive regulation of gamma-delta T cell differentiation | 3.491813e-2 |
GO:0046544 | development of secondary male sexual characteristics | 3.584939e-2 |
GO:0042276 | error-prone translesion synthesis | 3.584939e-2 |
GO:0043966 | histone H3 acetylation | 3.608340e-2 |
GO:0048663 | neuron fate commitment | 3.636580e-2 |
GO:0032276 | regulation of gonadotropin secretion | 3.731474e-2 |
GO:0032098 | regulation of appetite | 3.759625e-2 |
GO:0031323 | regulation of cellular metabolic process | 3.778435e-2 |
GO:0006412 | translation | 3.779836e-2 |
GO:0046676 | negative regulation of insulin secretion | 3.785726e-2 |
GO:0030513 | positive regulation of BMP signaling pathway | 3.785726e-2 |
GO:0048769 | sarcomerogenesis | 3.797779e-2 |
GO:0000902 | cell morphogenesis | 3.797913e-2 |
GO:0060137 | maternal process involved in parturition | 3.800001e-2 |
GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process | 3.800001e-2 |
GO:0060014 | granulosa cell differentiation | 3.800001e-2 |
GO:0070189 | kynurenine metabolic process | 3.855806e-2 |
GO:0048012 | hepatocyte growth factor receptor signaling pathway | 3.855806e-2 |
GO:0072527 | pyrimidine-containing compound metabolic process | 3.864154e-2 |
GO:0022403 | cell cycle phase | 3.877540e-2 |
GO:0051351 | positive regulation of ligase activity | 3.915865e-2 |
GO:0050930 | induction of positive chemotaxis | 3.915865e-2 |
GO:0031324 | negative regulation of cellular metabolic process | 3.981490e-2 |
GO:0000042 | protein targeting to Golgi | 3.982226e-2 |
GO:0090329 | regulation of DNA-dependent DNA replication | 3.982226e-2 |
GO:0006222 | UMP biosynthetic process | 3.982226e-2 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 3.989452e-2 |
GO:0043117 | positive regulation of vascular permeability | 4.019866e-2 |
GO:0030497 | fatty acid elongation | 4.033147e-2 |
GO:0042384 | cilium assembly | 4.076758e-2 |
GO:0051798 | positive regulation of hair follicle development | 4.110727e-2 |
GO:0032317 | regulation of Rap GTPase activity | 4.110727e-2 |
GO:0050918 | positive chemotaxis | 4.139133e-2 |
GO:0048247 | lymphocyte chemotaxis | 4.241297e-2 |
GO:0016137 | glycoside metabolic process | 4.244420e-2 |
GO:0002331 | pre-B cell allelic exclusion | 4.244420e-2 |
GO:0032700 | negative regulation of interleukin-17 production | 4.373928e-2 |
GO:0032863 | activation of Rac GTPase activity | 4.373928e-2 |
GO:0016338 | calcium-independent cell-cell adhesion | 4.448559e-2 |
GO:0003211 | cardiac ventricle formation | 4.460322e-2 |
GO:0061033 | secretion by lung epithelial cell involved in lung growth | 4.473554e-2 |
GO:0035270 | endocrine system development | 4.506094e-2 |
GO:0006479 | protein methylation | 4.538198e-2 |
GO:0050772 | positive regulation of axonogenesis | 4.585525e-2 |
GO:0060364 | frontal suture morphogenesis | 4.645331e-2 |
GO:0048339 | paraxial mesoderm development | 4.689466e-2 |
GO:0042401 | cellular biogenic amine biosynthetic process | 4.699675e-2 |
GO:0070346 | positive regulation of fat cell proliferation | 4.707158e-2 |
GO:0060447 | bud outgrowth involved in lung branching | 4.707158e-2 |
GO:0060435 | bronchiole development | 4.707158e-2 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 4.707158e-2 |
GO:0014060 | regulation of epinephrine secretion | 4.707158e-2 |
GO:0045669 | positive regulation of osteoblast differentiation | 4.717759e-2 |
GO:0071105 | response to interleukin-11 | 4.724490e-2 |
GO:0002731 | negative regulation of dendritic cell cytokine production | 4.724490e-2 |
GO:0060628 | regulation of ER to Golgi vesicle-mediated transport | 4.724490e-2 |
GO:0045221 | negative regulation of FasL biosynthetic process | 4.724490e-2 |
GO:0071392 | cellular response to estradiol stimulus | 4.784081e-2 |
GO:0007256 | activation of JNKK activity | 4.784081e-2 |
GO:0042026 | protein refolding | 4.784081e-2 |
GO:0001570 | vasculogenesis | 4.860947e-2 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 4.885465e-2 |
GO:0008406 | gonad development | 4.933067e-2 |
GO:0043490 | malate-aspartate shuttle | 4.945126e-2 |
GO:0070350 | regulation of white fat cell proliferation | 4.945126e-2 |
GO:0010700 | negative regulation of norepinephrine secretion | 4.945126e-2 |
GO:0001672 | regulation of chromatin assembly or disassembly | 4.945126e-2 |
GO:0003207 | cardiac chamber formation | 4.947071e-2 |
GO:0000070 | mitotic sister chromatid segregation | 5.163265e-2 |
GO:0045617 | negative regulation of keratinocyte differentiation | 5.212391e-2 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 5.247588e-2 |
GO:0060485 | mesenchyme development | 5.285175e-2 |
GO:0007212 | dopamine receptor signaling pathway | 5.345470e-2 |
GO:0034067 | protein localization in Golgi apparatus | 5.359141e-2 |
GO:0048557 | embryonic digestive tract morphogenesis | 5.387828e-2 |
GO:0046477 | glycosylceramide catabolic process | 5.433731e-2 |